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Abstract. Human alloimmune cytotoxic Τ cells, sensitized selectively against the
HLA-A2 antigen, were tested on a panel of selected target cells. Five HLA-A2
positive outlier cells could be ldentified. These outlier cells were only weakly
lysed by HLA-A2 specific CTLs, although they were serologically indistinguish-
able from the other HLA-A2 positive, strongly lysed target cells. Furthermore, it
was found that the outlier cells were poor cold target inhibitors in contrast to the
other HLA-A2 positive target cells, which showed adequate Inhibition of specific
lysis of HLA-A2 positive target cells. Population studies indicate that the
frequency of such HLA-A2 outlier cells may be approximately 10%.
Introduction
It is generally accepted that gene products of the major histocompatibility complex
(MHC) play an important role in cell mediated lympholysis (CML) both in the
induction phase and m the recognition phase of allogeneic cytotoxic Τ lymphocytes
(CTLs). The antigens recognized by allogeneic CTLs were initially shown to be the
serologically defined HLA-A, -B and -C antigens (Miggiano et al. 1972, Eijsvoogel et
al. 1976, Grunnet et al. 1976), but also the HLA-D region products were proven to
be target antigens (Mawas et al. 1975, Albrechtsen et al. 1979, Feighery and Stastny
1979, Johnsen 1980). Apart from the serologically defined antigens, CTLs were
shown to recognize other determinants (Kristensen et al. 1974, Schapira and
Jeannet 1974, Willumsen and Heron 1974, Sondel et al. 1975). One group of
determinants recognized by allogeneic CTLs comprises the splits or subtypes of
serologically defined antigens (Goulmy et al. 1976, Long et al. 1976, Bradley et al.
1978, Schendel et al. 1978, Kato et al. 1982) for which there is not always as yet a
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serologically dcfincd counterpart Biddison and co-workers (1980a) described an
HLA-A2 vananU which by virus immune CTLs and an HLA-A2restnctcd anti-H-
Y CTL (Goulmy et al 1982), was shown lo be rccognized differently from most other
IILA-A2 positive cells Anothcr possiblc HLA-A2 vanant,detected by an HLA-A2
reslricted anti-H-Y CTL, was reccntly described by Pfeffer and Thorsby (1982)
Wc icport here the rcsults of a systematic study on the occurrence of
serologically HLA-A2 positive cells, which are not or only minimally lysed by
alloimmune HLA-A2 specific CTLs Approximately 10% of a randomly selected
panel of HLA-A2 positive individuals could be identified as couther cells
Hirthermore, the outlier cells can be divided into different subscts
Materials and Methods
Ctff dt»wrs CLII donors wcre scleeted from our files of HLA-A B, C and DR lyped, healthy blood
dotiors Selecuon was eilher perfoimcd randomly or according to Η LA phenotypes in order to obUun
C Π s diiCLted agamsl (he Serologie illy defined Η LA A2 anttgen
CML itihnujut CML was performed acc-ording lo the Luropean Standard techniqucff uiopean CML-
gioup rcporl III 1980) In btief mduecr eulturcs (1 e slandard mixed lympliocyte oultures) were
estiblishcti for 6 days foilowed by CML lesling (4 h) at four different CfL diluiions against 104 s l Cr
labelcd PilA-itimiilatu! (3 days) lymphoblasts
Cold larcftl Inhibition 1 bt CML Inhibition capauly of seleclcd cells was tested by addition of non-^'Ci
labcSed (cold) PH Α sümulated ceJls to the specifib combinalion (c g effector ABX agamsl 51Cr labcled
target cctli, U) Α nxed numbt-r of cold targets {105} was added to 104 hot largets at diffetenl CTL/hoV
target CLII latios Control values wcre esl iblislied by idding cold competitorb autologous cither to the
responder or the stimul itor eclis
Caliulation of nsults Cytotoxiuty wa calculatcd for each CTL/larget ratio a.ccordmglo the formula
(expcrnncntal hpontancous) cpm
— - χ [0Ü = percent relctse(maximitm spontaneous) cpm
The LXpLnmLiilal resuKs fioni diffurLni expctimenls wcre normalized to a peretnt relative cytoloxic
response (perccnl RCR) b jsed on tlie 'pecific icsponsc for a given CTL and calciil ited by the foimula
percenl teleasc of cxpenmcntal target
- - - χ 100 = pei cent RCR
pcreuil rue \st of sptufic largcl
In all (.xpcnniLiiis described liic pcrcuilRCR wascalculated based on the peicentreleiscobbtivcd Μ Α
C Π/luget latio of40 I
Ahsoipiion of ULA Λ2 antisua 1ILA-A2 specifie anliscra were abiorbed using 2 χ 10ri cells per ml of
serum for 10 min at loom temperature UnslimuJated penpheral blood lymphocy'cs Pt-IA stimuidVcd
lymphoeyles tnd Γ pstem Bari viru^ transformed cefls were used for absorplions The absorbed antiscra
wtre iested on setecteci cells in the National Institutes of Uuilth lechnique
Results
IILA-A2 specific CTLsfatl tolysesomeseroloifitally definedHLA-A2positive tarqet
i W/s
Ι η the expenments that initiated Uns study, lt was noted that the percent lysis of an
HLA-A2 specific CTL against three HLA-A2 positive target cells was marginal
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compared with the percent lysis against the specific target cells and most other
HLA-A2 positive target cells Since this phenomenon was reproducible, an
expanded panel of HLA-A2 positive target cells was subsequently studied using a
number of allogeneic CTLs
Four different CTLs were generated against the HLA-A2 antigen between
unrelated individuals The HLA-A, -B, -C and -DR genotypes of (he responder and
stimulator cells us,ed and the percent lysis of each CTL against autologous and
specific target are hsted in Table 1 Cytotoxicity of the CTLs against the
corresponding specific target cells langed from 51-78% lysis at CTL to targel ratio
40 1 Marginal cytotoxicity rangmg from 0-4% lysis was observed against the
corresponding autologous targets
The results of the panel study in which 58 HLA-A2 positive and 28 HLA-A2
negative target cells have been tested are presented in Figure 1 Α clearcut bimodal
distnbution of positive and negative targets was observed As expected, all CTLs
lysed most of the HLA-A2 positive target cells strongly (60% RCR or more), while
the HLA-A2 negative targels, wilh only a few exceptions, had RCR of 20% or less
The three target cells mentioned dbove (designated LV1, LV2 and LV3) were
recognized by all HI A-A2 specific CTLs tested, ι e , as outlier cells their RCR was
well below 60% Furlhermore.two additional outlier cells (designated LV4 and LV5)
were identified, which were consistently lysed less efficiently by two of the CTLs (ι e,
CTL1 and 2) However, LV4 and LV5 were not recognized as outlier cells by CTL3
and 4
Inhibition of lysis by outlier cold compelitor cells
The HLA-A2 outlier cells were also tested as cold competitors for cytotoxicity
against "normal" HLA-A2 51Cr-labeled target cells As shown for one HLA-A2
specific CTL in Figure 2, none of the outlier cells was capable of inhibiting the
specific lysis In this respect they behaved the same as cold competitors, which were
Table 1 HLA genotypes of responder stimulator combinations and percent CML agunst lutologous
and specific larget cells
Lffcctor
cells
CTLI
CTL24
CTL3 +
CTL4*
Responder cel
A3
All
AI
AI
AI
A2S
AI
A25
Bw35
B5
B8
Bw44
B8
B44
B8
B44
ls
Cw4
Cw5
Cw5
DRI
DR4
DRI
DRw6
DRI
DR3
DRI
DR3
Stimulator cells
A2
A2
AI
A2
AI
A2
AI
A2
B5
B5
B8
B44
B8
B44
B8
B44
Cw2
Cw4
Cw5
Cw5
DR4
DR7
DR3
DR 3
DR3
DR3
DR3
DR4
Percent lysis*
Autologous1
4
0
2
3
Specific
78
67
51
56
* Percent lysis at effector to target n ü o 40 1
Titigei cells from rapondtr ceJl aonor (autologous) and sMmul itor feil donor (specific)
CTL2 and 3 were generated against the same stimulator cell white CTL1 and 4 were the same
responder cell directed against two different stimulator cells
% RCR
UO -ι
r
CTL 1
Fiy 1 1'ua.nt i t l t t ivc cytoloxic rcsponses of
III Λ Λ2 spccific C I Ls Opcn urtJcs icpicsui l
1 ILA Λ2 positive t uy-t cclls Closcd urclcs repix
seilt HLA A2 ne^ilivc Eny-t cells ü i t oullicr
!l[ Α A2 posihve l u g e t teils I VI t V5 ire num
beied 1 ^ 1 4 ind 5 resptxlivcly IILA pheno
types of I V] to LV5
I VI
IV2
A I
Bw6
Λ2
Bw6
Λ2
_
Λ2
Bw6
A2
Iiwfi
Λ2
Cw6
Aw29
-
Λ26
Cw2
A I
Cw4
Aw32
Cwfi
I!K
Cw7
B7
1)27
Cw6
1!«
Bw44
Bw50
DR1
Bw58
DRwf,
i m
DRw6
Bw15
OR2
Bw50
DRI
DR 7
Bw4
-
Bw4
DRw9
-
„
Bw4
DR7
HLA-A2 negative or
 (is the autologous cells On the other hand, all strongly lysed
HLA-A2 positive target cells tested werc dble to block specific lysis although the
amounl of blocking showcd some vanation
SirolüLjKai cvaluation
Serologitdl analysis using alloimmunc serd with proven specificity for the 1 ILA A2
antigen Wds ptrformcd to confirm the presence of the IILA A2 dntigen on the
fivc outlier cells diid on ι andomly chosen strongly lysed target celL As expected, all
cells carncd the serologic.illy defined HLA-A2 specificily As shown in Table 2
positivity in CML and the presence of the serological HLA A2 antigcn werc highly
associatcd for all four CTLs (p<000()l by chi-squarc analysis with Ydtes
correction)
Diflciential rccogmüon of Η LA Λ2
% Ly
100-,
Fig 2 Cold Lirget mhtbtlton oi<m HLA
A2 sptcific CTL CTL 1 wjs testcd on
spctific Simulator 1 irgcl cctls (targcl no
7) Cold targct 1 2, 3 4, md 5 conespond
with the ouUier cells I VI LV5 wlule cold
larget 6 ind 8 irc two normal Η LA A2
positive Uu get cells The perctnl lysis»
wilhout adtliiion of coid target ceHs> is
indiuitcd by —
Η LA phutoiypcs ce)l 6
A2 Awil Iiw"i8 Bw44
Bw4 Cw2 DR2 DRw6
HI Α phenolypes ccll 8
Λ2 A3 Bw62 -
Bw6 Cwi OR1 DRw6
lal>lc 2 Correhlion strology and CML
IILAA2*
CML*
CI Ll 2
51
5 28
CML'
CTL3 4
* The presence ofthe scrologically defined HLA A2 antigen was lested with the aHoanliscia VR46"U6
and VR49484, whioh arc used as lyping sera in our deparlmcnt
1
 Susteptibihty of targU cclls lo lysis by CTLs duected againbi the HLA-A2 untigen
Two sera werc absorbed with three ofthe ouüicr cells and three conti ol cells The
resuhs m Table 3 show Ihat all HLA-A2 positive cells dh>oibed the anti-HLA-A2
activity One absorption was sufficient to remove the anli-HLA-A2 activity
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1 ablc 3 Absorption of Η LA Λ2 anlist-r ι by outlier <md control eells
Absorbin^ uA\*
NüllL
1 VI
LV2
IV!
Contro) 1'
Control 2
Conlrol 3
Serum
VR46M6
-
4-
Serum
V11494841
4-
4-
* fhe ibsorbm^ cells shown in thts t\ble were EBV tr insibrmed cells However no differences in
ibsorbm^, c ip tuty were observed when imstimulated lymphocytes or PH Α stimuiated lymphocytes
were used for ibsorplion
I lictiler oilheseium before tbsorplion wis 1 16 Noresiduilreactivity was observed after absorpüon
wilb HLA Λ2 positive cetls
1
 Re ictivity of tlic sera w is tcslcd back on the five outher cclls tnd five r indomly chosen olher Η LA A2
positive cclls
1 be HLA phenolypes of oontrol cells arc
Ι Λ2 BIS Hwf) Cwi DR4
2 A2 Uwl6 Bw4 DRw6
1 A9 B7 Bw4 DR2
completely No differences in absorbing Ciipacity was observed between un
stimulated penpheral blood lymphocytes PHA stimulated lymphocytes, and EBV
transformed cells
Discussion
In this study evidence is presented that CTLs directed against the serologically
defmed HLA A2 antigen lysed the majonty of HLA A2 positive target ceüs
stiongly Howevt-r in a System itic study compnsing a panel of 58 HLA A2 positive
t irget cells five outlier cells were identified which were lysed consistently with Iow
efficicney All oullier cells were positive for the HLA A2 antigen as analyzed with
well defined alloimmune antisera specific for the A2 antigen When the outliei cells
were tested as cold competnors, cytotoxicity against the specific target was hardly
blocked lfatall AllotherHLA A2 positive target cells could block the specific lysis
Since the CTLs were highly specific for the serologically defmed HLA A2 antigen
Ihc Mmplest Interpretation is that the target antigen recognized by the cytotoxic Τ
celUistheHLA A2 antigen ltself Ourdata would then indicate thal around 10y of
the seiologically defined HLA A2 antigens are vanant or subtype
Α diffeience was observed in cytotoxic capacity between CTLs 1 and 2 as
compared with CTLs 1 and 4 The latter CTLs lysed the outlier cells LV4 and LV5
slrongly (RCR above 60/) To clanfy these differences in cytotoxic capacity scveral
possibihties can be considered First cytotoxic responses in bulk eultures aie
polyclonal thus several cytotoxic determinants might be recogm?ed by clones
pi esent in the bulk population of CTLs tested Since responder and stimulator cells
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share HLA-Al, B8 and -B12 antigens, cytotoxic determinants associated with
HLA B8 and -B12 (as descnbed by Christiansen et al 1981 and Kato et al 1982)
may play a role Interestingly, CTL2, which was generated against the same
stimulator cell as CTL3, apparently did not recognize those extra specificities
Second, CTL3 and CTL4 recognize diffeient epitopes of the HLA-A2 antigen as
cytotoxic determinant, thereby deßmng a heterogeneity within a heterogeneity
Prehminary results show that CTLs directed against the HLA-A2 antigens of the
outlier cells indeed subdivide HLA-A2 into at least three bubtypes (J J van der Poel,
J Pool and Ε Goulmy, manuscnpt in preparation) Biddison and co-workers
(1980b) documented chemical differences in the heavy polypeptide chain of an
HLA-A2 vanant that was detected by virus immune CTL Based on these
observations, biochemical studies are in progress to document a molecular basis for
the differential recognition of the HLA-A2 antigen using allogeneic CTLs as
reagents
Population studies of CTLs between genotypically (Goulmy et al 1976) or
phenotypically HLA identical individuals (Schapira and Jeannet 1974, Robinson et
al 1978, Kato et al 1982) have demonstrated the existence of cytotoxic de-
terminants that are sei ologically indistmguishable Recently, Biddison and co-
workers (1981) reported that virus immune CTLs recognized different epitopes of
HLA-A 3 antigens in conjunction with different types of mfluenza virus Since five
independent HLA A2 outher cells could be documented m this study, the same
could hold tiue for the outlier cells in an mfluenza virus restncted System
The present study supportf> the notion that the polymorphism of HLA gene
products IS greater than anticipated The picture that arises for a number of HLA
gene products resembles the complexity of target determinants descnbed in mouse
Π-2-Κ mutants (Mehef et al 1980, Sherman 1981)
Finally, lt seems of importance to document the influence of the Variation of
MHC antigens which is serologically indistmguishable but CTL distinguishable,
on the occurrence of kidney graft rejection This may document the bioiogical
relevance of vanations in MHC antigens in transplantation biology and infectious
diseases, e g viral infections
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